Acknowledgement
Supported by : Ministry of Education, Culture, Sports, Science and Technology, Japan
References
- Abdulqadhr G, Molin D, Astrom G, et al (2011). Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Acta Radiol, 52, 173-80. https://doi.org/10.1258/ar.2010.100246
- Cheran SK, Nielsen ND, Patz EFJr (2004). False-negative findings for primary lung tumors on FDG positron emission tomography. Staging and prognostic implications. AJR, 182, 1129-32. https://doi.org/10.2214/ajr.182.5.1821129
- Darge K, Jaramillo D, Siegel MJ (2008). Whole-body MRI in children: current status and future applications. Eur J Radiol, 68, 289-98. https://doi.org/10.1016/j.ejrad.2008.05.018
- Gong J, Cao W, Zhang Z, et al (2015). Diagnostic efficacy of whole-body diffusion-weighted imaging in the detection of tumour recurrence and metastasis by comparison with 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography or computed tomography in patients with gastrointestinal cancer. Gastroenterol Rep, 3, 128-35. https://doi.org/10.1093/gastro/gou078
- Goo JM, Im JG, Do KH, et al (2000). Pulmonary tuberculoma evaluated by means of FDG PET. Findings in 10 cases. Radiol, 216, 117-21. https://doi.org/10.1148/radiology.216.1.r00jl19117
- Heusner TA, Kuemmel S, Koeninger A, et al (2010). Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging. Eur J Nucl Med Mol Imaging, 37, 1077-86. https://doi.org/10.1007/s00259-010-1399-z
- Higashi K, Ueda Y, Seki H, et al (1998). Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med, 39, 1016-20.
- International Union Against Cancer (2009). TNM classification of malignant tumours. 7th ed. NY: Wiley-Liss, 138-46.
- Jain V, Hasselquist S, Delaney MD (2011). PET scanning in sarcoidosis. Ann N Y Acad Sci, 1228, 46-58. https://doi.org/10.1111/j.1749-6632.2011.06075.x
- Kim HS, Lee KS, Ohno Y, et al (2015). PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer. J Magn Reson Imaging, 42, 247-60. https://doi.org/10.1002/jmri.24776
- Konishi J, Yamazaki K, Tsukamoto E, et al (2003). Mediastinal lymph node staging by FDG-PET in patients with nonsmall cell lung cancer: analysis of false-positive FDG-PET findings. Respirat, 70, 500-6. https://doi.org/10.1159/000074207
- Kosucu P, Tekinbas C, Erol M, et al (2009). Mediastinal lymph nodes. Assessment with diffusion-weighted MR imaging. J Magn Reson Imaging, 30, 292-7. https://doi.org/10.1002/jmri.21850
- Kwee TC, Takahara T, Ochiai R, et al (2009). Whole-body diffusion-weighted magnetic resonance imaging. Eur J Radiol, 70, 409-17. https://doi.org/10.1016/j.ejrad.2009.03.054
- Lambregts DMJ, Maas M, Cappendijk VC, et al (2011). Wholebody diffusion-weighted magnetic resonance imaging: current evidence in oncology and potential role in colorectal cancer staging. Eur J Cancer, 47, 2107-16. https://doi.org/10.1016/j.ejca.2011.05.013
- Laurent V, Trausch G, Bruot O, et al (2010). Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT. Eur J Radiol, 75, 376-83. https://doi.org/10.1016/j.ejrad.2009.04.059
- Le Bihan D, Breton E, Lallemand D, et al (1988). Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiol, 168, 497-505. https://doi.org/10.1148/radiology.168.2.3393671
- Li B, Li Q, Nie W, et al (2014). Diagnostic value of wholebody diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: a metaanalysis. Eur J Radiol, 83, 338-44. https://doi.org/10.1016/j.ejrad.2013.11.017
- Lin WY, Hsu WH, Lim Kh, et al (2012). Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer. J Chin Med Assoc, 75, 203-8. https://doi.org/10.1016/j.jcma.2012.04.004
- Maturu VN, Agarwal R, Aggarwal AN, et al (2014). Dual-time point whole-body 18F-fluorodeoxyglucose PET/CT imaging in undiagnosed mediastinal lymphadenopathy: a prospective study of 117 patients with sarcoidosis and TB. Chest, 146, e216-20. https://doi.org/10.1378/chest.14-1827
- Michielsen K, Vergote I, Op de Beeck K, et al (2014). Wholebody MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET/CT. Eur Radiol, 24, 889-901. https://doi.org/10.1007/s00330-013-3083-8
- Nomori H, Mori T, Ikeda K, et al (2008). Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thoracic Cardiovasc Surg, 135, 816-22. https://doi.org/10.1016/j.jtcvs.2007.10.035
- Nomori H, Watanabe K, Ohtsuka T, et al (2004). Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3cm in diameter, with special reference to the CT images. Lung Cancer, 45, 19-27. https://doi.org/10.1016/j.lungcan.2004.01.009
- Ohno Y, Koyama H, Onishi Y, et al (2008). Non-small cell lung cancer: whole-body MR examination for M-stage assessment - utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiol, 248, 643-54. https://doi.org/10.1148/radiol.2482072039
- Plathow C, Aschoff P, Lichy MP, et al (2008). Positron emission tomography/computed tomography and wholebody magnetic resonance imaging in staging of advanced nonsmall cell lung cancer--initial results. Invest Radiol, 43, 290-7. https://doi.org/10.1097/RLI.0b013e318163273a
- Schmidt GP, Baur-Melnyk A, Herzog P, et al (2005). Highresolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol, 40, 743-53. https://doi.org/10.1097/01.rli.0000185878.61270.b0
- Schmidt GP, Kramer H, Reiser MF, et al (2007). Wholebody magnetic resonance imaging and positron emission tomography-computed tomography in oncology. Top Magn Reson Imaging, 18, 193-202. https://doi.org/10.1097/RMR.0b013e318093e6bo
- Schmidt GP, Reiser MF, Baur-Melnyk A (2009). Wholebody MRI for the staging and follow-up of patients with metastasis. Eur J Radiol, 70, 393-400. https://doi.org/10.1016/j.ejrad.2009.03.045
- Sommer G, Wiese M, Winter L, et al (2012). Preoperative staging of non-small-cell lung cancer: comparison of wholebody diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Eur Radiol, 22, 2859-67. https://doi.org/10.1007/s00330-012-2542-y
- Stecco A, Romano G, Negru M, et al (2009). Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study. Radiol Med, 114, 1-17. https://doi.org/10.1007/s11547-008-0348-4
-
Takano A, Oriuchi N, Tsushima Y, et al (2008). Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with
$^{18}F$ -FDG positron emission tomography and$^{123}I$ -MIBG scintigraphy. Ann Nucl Med, 22 , 395-401. https://doi.org/10.1007/s12149-008-0128-1 - Takenaka D, Ohno Y, Matsumoto K, et al (2009). Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging, 30, 298-308. https://doi.org/10.1002/jmri.21858
- Usuda K, Maeda S, Motono N, et al (2015). Diagnostic Performance of Diffusion-Weighted Imaging for Multiple Hilar and Mediastinal Lymph Nodes with FDG Accumulation. Asian Pac J Cancer Prev, 16, 6401-6 https://doi.org/10.7314/APJCP.2015.16.15.6401
- Usuda K, Sagawa M, Motono N, et al (2014). Diagnostic performance of diffusion weighted imaging of malignant and benign pulmonary nodules and masses. Comparison with positron emission tomography. Asian Pac J Cancer Prev, 15, 4629-35. https://doi.org/10.7314/APJCP.2014.15.11.4629
- Usuda K, Sagawa M, Motono N, et al (2013). Advantages of diffusion-weighted imaging over positron emission tomography-computed tomography in assessment of hilar and mediastinal lymph node in lung cancer. Ann Surg Oncol, 20, 1676-83. https://doi.org/10.1245/s10434-012-2799-z
- Usuda K, Zhao XT, Sagawa M, et al (2011). Diffusion-weighted imaging is superior to PET in the detection and nodal assessment of lung cancers. Ann Thorac Surg, 91, 1689-95. https://doi.org/10.1016/j.athoracsur.2011.02.037
-
van Ufford HME, Kwee TC, Beek FJ, et al (2011). Newly diagnosed lymphoma: initial results with whole-body T1-weighted, STIR, and diffusion-weighted MRI compared with
$^{18}F$ -FDG PET/CT. AJR Am J Roentgenol, 196, 662-9. https://doi.org/10.2214/AJR.10.4743 - Xue HD, Li S, Sun HY, et al (2008). Experimental study of inflammatory and metastatic lymph nodes with diffusion weighted imaging on animal model: comparison with conventional methods. Chin Med Sci J, 23, 166-71. https://doi.org/10.1016/S1001-9294(09)60033-X